These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1756 related items for PubMed ID: 3277796

  • 1. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J.
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [Abstract] [Full Text] [Related]

  • 2. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J.
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [Abstract] [Full Text] [Related]

  • 3. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
    Sindet-Pedersen S.
    Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
    [Abstract] [Full Text] [Related]

  • 4. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 5. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S.
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [Abstract] [Full Text] [Related]

  • 6. [Hemostatic balance during treatment with the newest contraceptives].
    Petersen KR, Skouby SO, Sidelmann J, Jespersen J.
    Ugeskr Laeger; 1994 Jan 10; 156(2):187-90. PubMed ID: 8296409
    [Abstract] [Full Text] [Related]

  • 7. Haemostatic changes and the oral contraceptive pill.
    Norris LA, Bonnar J.
    Baillieres Clin Obstet Gynaecol; 1997 Sep 10; 11(3):545-64. PubMed ID: 9488791
    [Abstract] [Full Text] [Related]

  • 8. Blood viscosity and thrombosis: clinical considerations.
    Smith BD, La Celle PL.
    Prog Hemost Thromb; 1982 Sep 10; 6():179-201. PubMed ID: 6762612
    [Abstract] [Full Text] [Related]

  • 9. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S.
    Crit Care Med; 2003 Apr 10; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [Abstract] [Full Text] [Related]

  • 10. Fibrin formation and dissolution in women receiving oral contraceptive drugs.
    Ball AP, McKee PA.
    J Lab Clin Med; 1977 Apr 10; 89(4):751-62. PubMed ID: 845477
    [Abstract] [Full Text] [Related]

  • 11. [Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].
    Bauersachs R, Lindhoff-Last E, Ehrly AM, Kuhl H.
    Zentralbl Gynakol; 1996 Apr 10; 118(5):262-70. PubMed ID: 8701622
    [Abstract] [Full Text] [Related]

  • 12. [Dysfunction of fibrinolysis as a risk factor of thrombosis].
    Kołodziejczyk J, Wachowicz B.
    Pol Merkur Lekarski; 2009 Oct 10; 27(160):341-5. PubMed ID: 19928667
    [Abstract] [Full Text] [Related]

  • 13. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
    Petersen KR, Sidelmann J, Skouby SO, Jespersen J.
    Am J Obstet Gynecol; 1993 Jan 10; 168(1 Pt 1):32-8. PubMed ID: 8420344
    [Abstract] [Full Text] [Related]

  • 14. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P, Loner U, Kapiotis S, Handler S, Schneider B, Huber J, Speiser W.
    Thromb Haemost; 1996 Nov 10; 76(5):729-34. PubMed ID: 8950781
    [Abstract] [Full Text] [Related]

  • 15. Reducing the risk of oral contraceptive-induced thrombosis.
    Pizzo SV.
    Drug Ther (NY); 1981 Sep 10; 11(9):101-8. PubMed ID: 12263495
    [Abstract] [Full Text] [Related]

  • 16. Protein C.
    Esmon CT.
    Prog Hemost Thromb; 1984 Sep 10; 7():25-54. PubMed ID: 6099583
    [Abstract] [Full Text] [Related]

  • 17. Action of hormonal contraceptives on the coagulation system and some of its inhibitors.
    Misz M, Beck P.
    Acta Med Hung; 1986 Sep 10; 43(3):301-10. PubMed ID: 2438639
    [Abstract] [Full Text] [Related]

  • 18. Pathophysiology of thrombophilic states.
    Mammen EF.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Sep 10; 115(3):243-52. PubMed ID: 2465210
    [Abstract] [Full Text] [Related]

  • 19. Disseminated intravascular coagulation and the balance between blood coagulation and fibrinolysis.
    Astrup T, Jespersen J.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984 Sep 10; 111(4):407-15. PubMed ID: 6083904
    [Abstract] [Full Text] [Related]

  • 20. Balance of coagulation activity with fibrinolysis during use of oral contraceptives in women with insulin-dependent diabetes mellitus.
    Petersen KR, Skouby SO, Jespersen J.
    Int J Fertil Menopausal Stud; 1995 Sep 10; 40 Suppl 2():105-11. PubMed ID: 8574252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 88.